SAADAT ANSARI: Open Payments
NPI 1861420994 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,235 in 41 payments from 10 companies in 2025. Trend: 2023 $1,385 · 2024 $1,237 · 2025 $1,235
Food & beverage: $1,235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $305 |
| Indivior Inc. | 4 | $205 |
| GlaxoSmithKline, LLC. | 9 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $152 |
| AstraZeneca Pharmaceuticals LP | 4 | $140 |
| Braeburn Inc. | 3 | $71 |
| Lundbeck LLC | 3 | $60 |
| Dexcom, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Novo Nordisk Inc | 2 | $42 |
Products named: VRAYLAR, SUBLOCADE, CAPLYTA, SHINGRIX, FARXIGA, BRIXADI, BREZTRI, REXULTI.
Industry payments across AL — which companies pay providers there.
